Acadia Pharmaceuticals

Red light traffic
Pharma

Acadia pushes for re-review of CHMP's Daybue snub

European regulators recently turned down Acadia's rare disease drug based on qualms with its pivotal Lavender study in Rett syndrome patients.
Zoey Becker Mar 3, 2026 11:45am
Lifeline
Favicon Fierce Biotech

Midsize biotechs form coalition to fight against MFN policy

Feb 25, 2026 1:05pm
A compass pointing at brand on the dial

Acadia, e-therapeutics unveil rebrands

Oct 2, 2025 11:11am
Graphic of arrows missing the target

After trial failure, Acadia scraps Prader-Willi candidate

Sep 24, 2025 3:29pm
Prompt agency of the year Fierce Pharma Marketing Awards 2025

Sanofi wins big at the 2025 Fierce Pharma Marketing Awards

Sep 11, 2025 8:32am
FDA

FDA approves Soleno's Vykat XR for insatiable hunger disorder

Mar 27, 2025 11:24am